TY - JOUR
T1 - Syntheses de l'Acide (2R, 3S); (2S, 3R) Agarique (14C‐4) et de l'Acide (2R, 3R); (2S, 3S) Agarique (3H‐4,4,5,5)
AU - Lellouche, J. P.
AU - Beaucourt, J. P.
AU - Pichat, L.
PY - 1984/2
Y1 - 1984/2
N2 - (2R, 3S); (2S, 3R) [4‐14C] Agaric acid and (2R, 3R); (2S, 3S) [4,4,5,5‐3H] agaric acid were synthesized from respectively threo methyl 1,2‐epoxypropane‐1,2,3‐tricarboxylate 3 and erythro epoxide 2. Epoxy ring opening of 2 and 3 with [1‐14C] hexadecyl copper 10. gave respectively the analog 4 of agaric acid trimethyl ester and methyl [4‐14C]agaricate 5, which was hydrolyzed to 1a by lithium hydroxide in 1,2‐dimethoxyethane (DME). Epoxy ring trans opening of 2 with diethyl 1‐hexadecynylalane 9 gave the alcynyl derivative 7 which was saturated with tritium in presence of Pd/C to lead to 6. After hydrolysis (LiCH + DME), 1b was obtained. The structures of the diastereoisomers (2R, 3R); (2S, 3S) 1b and (2R, 3S); (2S, 3R) 1a rest on 1H‐NMR.
AB - (2R, 3S); (2S, 3R) [4‐14C] Agaric acid and (2R, 3R); (2S, 3S) [4,4,5,5‐3H] agaric acid were synthesized from respectively threo methyl 1,2‐epoxypropane‐1,2,3‐tricarboxylate 3 and erythro epoxide 2. Epoxy ring opening of 2 and 3 with [1‐14C] hexadecyl copper 10. gave respectively the analog 4 of agaric acid trimethyl ester and methyl [4‐14C]agaricate 5, which was hydrolyzed to 1a by lithium hydroxide in 1,2‐dimethoxyethane (DME). Epoxy ring trans opening of 2 with diethyl 1‐hexadecynylalane 9 gave the alcynyl derivative 7 which was saturated with tritium in presence of Pd/C to lead to 6. After hydrolysis (LiCH + DME), 1b was obtained. The structures of the diastereoisomers (2R, 3R); (2S, 3S) 1b and (2R, 3S); (2S, 3R) 1a rest on 1H‐NMR.
UR - http://www.scopus.com/inward/record.url?scp=0021253935&partnerID=8YFLogxK
U2 - 10.1002/jlcr.2580210206
DO - 10.1002/jlcr.2580210206
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
SN - 0362-4803
VL - 21
SP - 125
EP - 132
JO - Journal of Labelled Compounds and Radiopharmaceuticals
JF - Journal of Labelled Compounds and Radiopharmaceuticals
IS - 2
ER -